Kanami Yamazaki

Ariake, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Metabolically inducing defects in DNA repair sensitizes BRCA-wild-type cancer cells to replication stress.

Metabolically inducing defects in DNA repair sensitizes BRCA-wild-type cancer cells to replication stress.

Journal: Science signaling

Published: November 12, 2024

Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling.

Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling.

Journal: Oncology research

Published: March 28, 2023

Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.

Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.

Journal: ACS chemical biology

Published: November 03, 2021

Suppression of tumor metastasis by a RECK-activating small molecule.

Suppression of tumor metastasis by a RECK-activating small molecule.

Journal: Scientific reports

Published: July 24, 2021

Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.

Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.

Journal: Scientific reports

Published: December 10, 2018

High-throughput screening in colorectal cancer tissue-originated spheroids.

High-throughput screening in colorectal cancer tissue-originated spheroids.

Journal: Cancer science

Published: September 06, 2018

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.

Journal: Oncotarget

Published: April 10, 2018

Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.

Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.

Journal: Cancer science

Published: July 28, 2014

In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA.

In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA.

Journal: Investigational new drugs

Published: July 04, 2014

AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy.

AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy.

Journal: The Journal of biological chemistry

Published: December 14, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026